Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
      • Applying for overseas supply of blood products
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
      • Applying for overseas supply of blood products
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR
Latest Updates

Patient Blood Management Guidelines progress update

  • Home
  • Patient Blood Management Guidelines progress update

Update of the Critical Bleeding Guideline

The Patient blood management guideline for adults with critical bleeding (2023) (Critical Bleeding Guideline) will be incrementally updated between 2027 to 2029 to keep it current and evidence based. At the project's conclusion, the guideline will be fully up to date.

Development process

To ensure recommendations are trustworthy and relevant to the Australian context, the update process involves:

  • the systematic review and critical appraisal of the latest research (scientific evidence)
  • input from clinical experts
  • stakeholder feedback
A Critical Bleeding Clinical/Consumer Reference Group (CRG) will:
  • review the evidence
  • use GRADE (Grading of Recommendations, Assessment, Development and Evaluation) to assess the certainty (or quality) of the evidence
  • develop recommendations.

The CRG may also 'adopt or adapt' recommendations from other high quality guidelines. The CRG may determine that a recommendation can be directly adopted for the Australian context or adapted to suit the Australian context.

As part of updating the Critical Bleeding Guideline, the NBA and CRG will trial elements of a living guideline model that will help us to assess long term options to maintain the clinical practice guidelines. 

Further information on guideline development can be found in the Guidelines for Guidelines Handbook(Opens in a new tab/window) and The Living Guidelines Handbook(Opens in a new tab/window).

Evaluation of the PBM & Rh D Ig Guidelines

The NBA intends to evaluate the effectiveness and future direction of the Patient Blood Management Guidelines and the Guideline for the prophylactic use of Rh D immunoglobulin in pregnancy care (Rh D Ig Guideline). 

 Over the next 12 months, we will consult widely to understand:

  • how the current guidelines are being used
  • key barriers and opportunities for strengthening PBM implementation
  • priority topics and emerging evidence in PBM or Rh D Ig prophylaxis
  • opportunities to improve the value, usability and presentation of the guidelines in practice.

The findings will inform our longer-term approach to updating and strengthening the PBM and Rh D Ig Guidelines, including the future scope, format and approach to updating the guidelines, and to supporting national PBM implementation.

Patient Blood Management education

BloodSafe eLearning Australia(Opens in a new tab/window) (BEA) provides free online courses relating to PBM and clinical transfusion practice for health professionals, including:

  • Clinical Transfusion Practice
  • Patient Blood Management
  • Acute Care and Surgical
  • Medical, Obstetrics, Neonates and Paediatrics
  • Iron Deficiency Anaemia.

Also available in the Resource Centre(Opens in a new tab/window) are free videos, tools and promotional materials.

Implementation activities

To support health providers in implementing the PBM Guidelines, we facilitate the development of free tools and materials.

Transparency

We would welcome your involvement - all stakeholders are invited to participate.

Subscribe to be kept up to date on PBM Guidelines updates and any opportunities to provide feedback and get involved by completing this subscription form(Opens in a new tab/window).

Get in touch 

We welcome comments and feedback on our guidelines which can be sent to guidelines@blood.gov.au. 

Last updated: 20 Jul 2026

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback